TickerFacts.

Lucid Diagnostics Inc. (LUCD): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$48.77M
Year ended 2025-12-31
-$49.81M
Trailing 12 months to 2026-06-30
2021-12-31: -$27.41M2022-12-31: -$54.31M2023-12-31: -$45.98M2024-12-31: -$44.88M2025-12-31: -$48.77M-$48.77M
2021-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$48.77Mn/m2026-03-25, From 2025-01-01
2024-12-31-$44.88Mn/m2026-03-25, From 2024-01-01
2023-12-31-$45.98Mn/m2025-03-24, From 2023-01-01
2022-12-31-$54.31Mn/m2024-03-25, From 2022-01-01
2021-12-31-$27.41Mn/a2023-03-14, From 2021-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Lucid Diagnostics Inc. (LUCD)2025-12-31-$48.77Mn/m
Picard Medical, Inc. (PMI)2025-12-31-$13.09Mn/m
Cerenome, Inc. (CNSY)2025-12-31-$14.85Mn/m
Intelligent Bio Solutions Inc. (INBS)2026-06-30-$11.44Mn/m
Tenon Medical, Inc. (TNON)2025-12-31-$12.53Mn/m
INVO Fertility, Inc. (IVF)2025-12-31-$6.56Mn/m
Beyond Air, Inc. (XAIR)2026-03-31-$25.94Mn/m
QHSLab, Inc. (USAQ)2025-12-31$222.0K-37.0%
InspireMD, Inc. (NSPR)2025-12-31$426.39M+73.0%

Compare LUCD, PMI, CNSY, INBS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗